Challenges of precision oncology for patients and oncologists

被引:0
作者
Goerling, Ute [1 ,2 ,3 ,4 ]
Rohrmoser, Amy [1 ,2 ,3 ,4 ]
Rueter, Gina [1 ,2 ,3 ,4 ]
Pichler, Theresia [5 ,6 ]
Westphalen, C. Benedikt [5 ,7 ]
Herschbach, Peter
机构
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Berlin Inst Hlth, Charite Comprehens Canc Ctr, Berlin, Germany
[5] Comprehens Canc Ctr Munich, Klinikum Rechts Isar, Partner Site TUM, Munich, Germany
[6] Comprehens Canc Ctr Munich, LMU Clin, Partner Site LUM, Campus Grosshadern, Munich, Germany
[7] Klinikum Univ Munchen, Med Klin & Poliklin 3, Munich, Germany
来源
ONKOLOGE | 2020年 / 26卷 / 08期
关键词
Psycho-oncology; Level of information; Molecular diagnostics; Expectations; Doctor-patient-communication; CANCER; MEDICINE; DISCLOSURE; ATTITUDES; THERAPY;
D O I
10.1007/s00761-020-00782-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Precision oncology is associated with high hopes of therapeutic success for affected patients. The data available on the clinical benefit of precision oncology approaches is inconsistent and the complexity of the subject matter places high demands on patient understanding. The management of these patients poses new challenges to the treating oncologists. Objectives This article reports on the current status of psycho-oncological research on the psychosocial burden of this patient group, their information needs, and the challenges for oncologists in connection with molecular diagnostics. Methods The basis for this was provided by a literature review and the results of our own investigations. Results Patients show high psychological stress and at the same time high hopes for molecular diagnostics. Transparent and continuous physician-patient communication, which includes patient-oriented education and consultation, is necessary to ensure informed consent in the context of precision oncology. Conclusion Psychological stress in patients in connection with precision oncology should be systematically investigated and identified at an early stage. These can be mitigated by specific physician-patient communication. One of the tasks of psycho-oncology today is to provide supporting measures.
引用
收藏
页码:746 / 751
页数:6
相关论文
共 34 条
[11]   Information Needs of Cancer Patients and Perception of Impact of the Disease, of Self-Efficacy, and Locus of Control [J].
Keinki, C. ;
Seilacher, E. ;
Ebel, M. ;
Ruetters, D. ;
Kessler, I. ;
Stellamanns, J. ;
Rudolph, I. ;
Huebner, J. .
JOURNAL OF CANCER EDUCATION, 2016, 31 (03) :610-616
[12]  
Klein F, 2020, FOKUS ONKOL, V23, P66
[13]   Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial [J].
Le Tourneau, Christophe ;
Delord, Jean-Pierre ;
Goncalves, Anthony ;
Gavoille, Celine ;
Dubot, Coraline ;
Isambert, Nicolas ;
Campone, Mario ;
Tredan, Olivier ;
Massiani, Marie-Ange ;
Mauborgne, Cecile ;
Armanet, Sebastien ;
Servant, Nicolas ;
Bieche, Ivan ;
Bernard, Virginie ;
Gentien, David ;
Jezequel, Pascal ;
Attignon, Valery ;
Boyault, Sandrine ;
Vincent-Salomon, Anne ;
Servois, Vincent ;
Sablin, Marie-Paule ;
Kamal, Maud ;
Paoletti, Xavier .
LANCET ONCOLOGY, 2015, 16 (13) :1324-1334
[14]   Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study [J].
Liang, R. ;
Meiser, B. ;
Smith, S. ;
Kasparian, N. A. ;
Lewis, C. R. ;
Chin, M. ;
Long, G. V. ;
Ward, R. ;
Menzies, A. M. ;
Harris-Wai, J. N. ;
Kaur, R. .
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
[15]   Revisiting Expectations in an Era of Precision Oncology [J].
Marchiano, Emily J. ;
Birkeland, Andrew C. ;
Swiecicki, Paul L. ;
Spector-Bagdady, Kayte ;
Shuman, Andrew G. .
ONCOLOGIST, 2018, 23 (03) :386-388
[16]   High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial [J].
Massard, Christophe ;
Michiels, Stefan ;
Ferte, Charles ;
Le Deley, Marie-Cecile ;
Lacroix, Ludovic ;
Hollebecque, Antoine ;
Verlingue, Loic ;
Ileana, Ecaterina ;
Rosellini, Silvia ;
Ammari, Samy ;
Ngo-Camus, Maud ;
Bahleda, Rastislav ;
Gazzah, Anas ;
Varga, Andrea ;
Postel-Vinay, Sophie ;
Loriot, Yohann ;
Even, Caroline ;
Breuskin, Ingrid ;
Auger, Nathalie ;
Job, Bastien ;
De Baere, Thierry ;
Deschamps, Frederic ;
Vielh, Philippe ;
Scoazec, Jean-Yves ;
Lazar, Vladimir ;
Richon, Catherine ;
Ribrag, Vincent ;
Deutsch, Eric ;
Angevin, Eric ;
Vassal, Gilles ;
Eggermont, Alexander ;
Andre, Fabrice ;
Soria, Jean-Charles .
CANCER DISCOVERY, 2017, 7 (06) :586-595
[17]  
Maughan T, 2017, NEW BIOETH, V23, P13, DOI 10.1080/20502877.2017.1314886
[18]   New challenges to psycho-oncology research: Precision medicine oncology and targeted therapies [J].
McFarland, Daniel C. ;
Blackler, Liz ;
Holland, Jimmie .
PSYCHO-ONCOLOGY, 2017, 26 (02) :144-146
[19]   Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care [J].
Miller, Fiona A. ;
Hayeems, Robin Z. ;
Bytautas, Jessica P. ;
Bedard, Philippe L. ;
Ernst, Scott ;
Hirte, Hal ;
Hotte, Sebastien ;
Oza, Amit ;
Razak, Albiruni ;
Welch, Stephen ;
Winquist, Eric ;
Dancey, Janet ;
Siu, Lillian L. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (03) :391-395
[20]   The evidence framework for precision cancer medicine [J].
Moscow, Jeffrey A. ;
Fojo, Tito ;
Schilsky, Richard L. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (03) :183-192